1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | 2026 | |
|---|---|---|
| Revenue | 351.06K | 4.62% |
| Gross profit | 351.06K | 4.62% |
| Net profit | 293.33K | 11.19% |
| EBITDA | 296.86K | 11.06% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €20.15M |
Number of shares | 3.99M |
52-week high/low | €6.10 - €2.50 |
| Dividends | No |
Beta | 0.78 |
P/E ratio | 0.00 |
PEG ratio | 0.00 |
P/B ratio | 0.00 |
P/S ratio | 57.40 |
Company profile
Die Biogena Group Invest AG beschäftigt sich mit der Bereitstellung von Nahrungsergänzungsmitteln. Das Unternehmen hat seinen Sitz in Salzburg, Österreich.
| Name | Biogena Group Invest |
| CEO | Julia Ganglbauer |
| Headquarters | Salzburg,
Austria |
| Website | |
| Sector | Consumer Staples |
| Industry | Food Products |
| IPO | 11/30/2020 |
| Employees | 3 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Vie | BIO.VI |
Wien | BIO.VI |
Discover assets
Shareholders of Biogena Group Invest also invest in the following assets
